Inhibition of P-gp in human K562/A02 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin IC5...

Basic Information

ID: ALA4192003

Type: Binding

Description: Inhibition of P-gp in human K562/A02 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin IC50

Format: BAO_0000219

Organism: Homo sapiens

Cell type: K562/A02

Target: Unchecked(ALA612545)

Document: ALA4190243

Inhibition of P-gp in human K562/A02 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin IC50: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4192003

Total(3)

Parent Molecular Weight	ALogP	Polar Surface Area
431.58	5.08	5.08
261.33	2.12	2.12
275.36	2.51	2.51

Parent Molecular Weight

ALogP

Polar Surface Area

431.58

5.08

261.33

2.12

275.36

2.51

Inhibition of P-gp in human K562/A02 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin IC5...

Basic Information

Activity Charts

Compound Summary